OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
OncoSec Medical reports 2018 executive compensation
By ExecPay News
Published: November 8, 2018
OncoSec Medical reported fiscal year 2018 executive compensation information on November 8, 2018.
In 2018, four executives at OncoSec Medical received on average a compensation package of $2.2M, a 202% increase compared to previous year.
Average pay of disclosed executives at OncoSec Medical
Daniel J. O'Connor, Chief Executive Officer, received $4.2M in total. 91% of O'Connor's compensation, or $3.8M, was in option awards. O'Connor also received $70K in bonus, $283K in salary, as well as $19K in other compensation.
Punit Dhillon, Chief Executive Officer, received a compensation package of $2.7M, which increased by 234% compared to previous year. 37% of the compensation package, or $982K, was in other compensation.
Sara Bonstein, Chief Financial Officer, earned $919K in 2018.
Richard Slansky, Chief Financial Officer, received $915K in 2018, which increases by 76% compared to 2017.
OncoSec Medical's fiscal year ends on July 31.
Related executives
You may also like
Source: SEC filing on November 8, 2018.